rwd from insight-mm: duration of therapy and treatment sequencing
Published 4 years ago • 23 plays • Length 2:02Download video MP4
Download video MP3
Similar videos
-
4:12
insight-mm: real-world patterns of patient characteristics
-
4:48
an insight into the management of cytopenias in mf
-
1:22
shortening the duration of treatment with fixed-duration or mrd-adapted regimens in cll
-
4:20
therapy-related all: etiology, prognosis, and treatment
-
1:52
single-cell and immune sequencing to predict response and resistance to car-t therapy in r/r mm
-
6:33
mrd as a tool to discontinue therapy in mm?
-
0:43
elm-2: qol and orr outcomes of odronextamab treatment for r/r fl
-
2:33
insights into the results and implications of the commands & imerge studies in lr-mds
-
5:16
the evolution of al amyloidosis therapy
-
1:23
management of high-risk newly diagnosed mm
-
2:45
responses in r/r mm treated with teclistamab following prior bcma-directed therapy
-
1:06
derive trial update: did vs dvd in newly diagnosed mm
-
3:17
estimating transfusion-related medical costs & time burden in patients with mf in simplify-1
-
2:09
heart transplantation in attr amyloidosis
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
1:13
horizon scan of mds treatments
-
2:12
navtemadlin and its role in the treatment of r/r myelofibrosis
-
1:22
maintenance therapy in mm: perspectives